nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—ALB—Fluorouracil—urinary bladder cancer	0.105	0.276	CbGbCtD
Oxcarbazepine—CYP3A4—Thiotepa—urinary bladder cancer	0.101	0.266	CbGbCtD
Oxcarbazepine—CYP3A5—Etoposide—urinary bladder cancer	0.0701	0.185	CbGbCtD
Oxcarbazepine—ALB—Methotrexate—urinary bladder cancer	0.0576	0.152	CbGbCtD
Oxcarbazepine—CYP3A4—Etoposide—urinary bladder cancer	0.0273	0.0721	CbGbCtD
Oxcarbazepine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0186	0.0492	CbGbCtD
Oxcarbazepine—Carbamazepine—UGT2B7—urinary bladder cancer	0.00272	0.389	CrCbGaD
Oxcarbazepine—Nepafenac—PTGS2—urinary bladder cancer	0.00114	0.163	CrCbGaD
Oxcarbazepine—Magnesium salicylate—PTGS2—urinary bladder cancer	0.00112	0.16	CrCbGaD
Oxcarbazepine—Piroxicam—PTGS2—urinary bladder cancer	0.00107	0.153	CrCbGaD
Oxcarbazepine—Salsalate—PTGS2—urinary bladder cancer	0.000949	0.136	CrCbGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTO2—urinary bladder cancer	0.000472	0.00907	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—NAT1—urinary bladder cancer	0.000472	0.00907	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000472	0.00906	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—CNTN2—urinary bladder cancer	0.00047	0.00902	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000466	0.00894	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.000465	0.00893	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—UGT2B7—urinary bladder cancer	0.000432	0.00829	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00043	0.00825	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000426	0.00818	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00042	0.00806	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000414	0.00796	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000409	0.00785	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP4B1—urinary bladder cancer	0.000389	0.00747	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTZ1—urinary bladder cancer	0.000385	0.0074	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000383	0.00736	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00038	0.00729	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—MPO—urinary bladder cancer	0.000378	0.00727	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTO2—urinary bladder cancer	0.000365	0.00701	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—NAT1—urinary bladder cancer	0.000365	0.00701	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000361	0.00694	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00036	0.00691	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00034	0.00654	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000339	0.00651	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—CNTN2—urinary bladder cancer	0.000335	0.00644	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—UGT2B7—urinary bladder cancer	0.000334	0.00641	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000329	0.00632	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000301	0.00577	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP4B1—urinary bladder cancer	0.000301	0.00577	CbGpPWpGaD
Oxcarbazepine—Stomatitis—Doxorubicin—urinary bladder cancer	0.0003	0.000533	CcSEcCtD
Oxcarbazepine—Rhinitis—Epirubicin—urinary bladder cancer	0.000299	0.000532	CcSEcCtD
Oxcarbazepine—Abdominal pain—Etoposide—urinary bladder cancer	0.000299	0.000532	CcSEcCtD
Oxcarbazepine—Body temperature increased—Etoposide—urinary bladder cancer	0.000299	0.000532	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000299	0.000532	CcSEcCtD
Oxcarbazepine—Hepatitis—Epirubicin—urinary bladder cancer	0.000298	0.000531	CcSEcCtD
Oxcarbazepine—Eye disorder—Methotrexate—urinary bladder cancer	0.000298	0.00053	CcSEcCtD
Oxcarbazepine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000298	0.00053	CcSEcCtD
Oxcarbazepine—Tinnitus—Methotrexate—urinary bladder cancer	0.000297	0.000529	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000297	0.000528	CcSEcCtD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000296	0.00569	CbGpPWpGaD
Oxcarbazepine—Asthenia—Cisplatin—urinary bladder cancer	0.000296	0.000527	CcSEcCtD
Oxcarbazepine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000296	0.000527	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000296	0.000526	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000294	0.000523	CcSEcCtD
Oxcarbazepine—Haematuria—Doxorubicin—urinary bladder cancer	0.000293	0.000522	CcSEcCtD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000292	0.00561	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000292	0.00561	CbGpPWpGaD
Oxcarbazepine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000291	0.000517	CcSEcCtD
Oxcarbazepine—Epistaxis—Doxorubicin—urinary bladder cancer	0.00029	0.000516	CcSEcCtD
Oxcarbazepine—Angiopathy—Methotrexate—urinary bladder cancer	0.000289	0.000515	CcSEcCtD
Oxcarbazepine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000288	0.000513	CcSEcCtD
Oxcarbazepine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000288	0.000512	CcSEcCtD
Oxcarbazepine—Dizziness—Fluorouracil—urinary bladder cancer	0.000288	0.000512	CcSEcCtD
Oxcarbazepine—Visual impairment—Epirubicin—urinary bladder cancer	0.000287	0.000512	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000287	0.000511	CcSEcCtD
Oxcarbazepine—Chills—Methotrexate—urinary bladder cancer	0.000286	0.000509	CcSEcCtD
Oxcarbazepine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000282	0.000503	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000282	0.000502	CcSEcCtD
Oxcarbazepine—Alopecia—Methotrexate—urinary bladder cancer	0.000282	0.000501	CcSEcCtD
Oxcarbazepine—Vomiting—Gemcitabine—urinary bladder cancer	0.000281	0.000501	CcSEcCtD
Oxcarbazepine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000281	0.0005	CcSEcCtD
Oxcarbazepine—Mental disorder—Methotrexate—urinary bladder cancer	0.000279	0.000497	CcSEcCtD
Oxcarbazepine—Rash—Gemcitabine—urinary bladder cancer	0.000279	0.000497	CcSEcCtD
Oxcarbazepine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000279	0.000496	CcSEcCtD
Oxcarbazepine—Eye disorder—Epirubicin—urinary bladder cancer	0.000279	0.000496	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000279	0.000496	CcSEcCtD
Oxcarbazepine—Tinnitus—Epirubicin—urinary bladder cancer	0.000278	0.000495	CcSEcCtD
Oxcarbazepine—Malnutrition—Methotrexate—urinary bladder cancer	0.000277	0.000494	CcSEcCtD
Oxcarbazepine—Headache—Gemcitabine—urinary bladder cancer	0.000277	0.000494	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000277	0.000493	CcSEcCtD
Oxcarbazepine—Flushing—Epirubicin—urinary bladder cancer	0.000277	0.000493	CcSEcCtD
Oxcarbazepine—Vomiting—Fluorouracil—urinary bladder cancer	0.000277	0.000493	CcSEcCtD
Oxcarbazepine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000277	0.000492	CcSEcCtD
Oxcarbazepine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000276	0.000491	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000275	0.000489	CcSEcCtD
Oxcarbazepine—Rash—Fluorouracil—urinary bladder cancer	0.000274	0.000488	CcSEcCtD
Oxcarbazepine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000274	0.000488	CcSEcCtD
Oxcarbazepine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000274	0.000488	CcSEcCtD
Oxcarbazepine—Headache—Fluorouracil—urinary bladder cancer	0.000273	0.000485	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000272	0.000484	CcSEcCtD
Oxcarbazepine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000272	0.000484	CcSEcCtD
Oxcarbazepine—Asthenia—Etoposide—urinary bladder cancer	0.000271	0.000483	CcSEcCtD
Oxcarbazepine—Angiopathy—Epirubicin—urinary bladder cancer	0.000271	0.000482	CcSEcCtD
Oxcarbazepine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000269	0.00048	CcSEcCtD
Oxcarbazepine—Back pain—Methotrexate—urinary bladder cancer	0.000268	0.000478	CcSEcCtD
Oxcarbazepine—Chills—Epirubicin—urinary bladder cancer	0.000268	0.000476	CcSEcCtD
Oxcarbazepine—Pruritus—Etoposide—urinary bladder cancer	0.000267	0.000476	CcSEcCtD
Oxcarbazepine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000266	0.000474	CcSEcCtD
Oxcarbazepine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000266	0.000473	CcSEcCtD
Oxcarbazepine—Alopecia—Epirubicin—urinary bladder cancer	0.000264	0.000469	CcSEcCtD
Oxcarbazepine—Nausea—Gemcitabine—urinary bladder cancer	0.000263	0.000468	CcSEcCtD
Oxcarbazepine—Vomiting—Cisplatin—urinary bladder cancer	0.000262	0.000467	CcSEcCtD
Oxcarbazepine—Vision blurred—Methotrexate—urinary bladder cancer	0.000261	0.000465	CcSEcCtD
Oxcarbazepine—Mental disorder—Epirubicin—urinary bladder cancer	0.000261	0.000465	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000261	0.000464	CcSEcCtD
Oxcarbazepine—Rash—Cisplatin—urinary bladder cancer	0.00026	0.000463	CcSEcCtD
Oxcarbazepine—Dermatitis—Cisplatin—urinary bladder cancer	0.00026	0.000463	CcSEcCtD
Oxcarbazepine—Malnutrition—Epirubicin—urinary bladder cancer	0.00026	0.000462	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—NAT2—urinary bladder cancer	0.000259	0.00497	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Etoposide—urinary bladder cancer	0.000259	0.00046	CcSEcCtD
Oxcarbazepine—Nausea—Fluorouracil—urinary bladder cancer	0.000259	0.00046	CcSEcCtD
Oxcarbazepine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000258	0.000459	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000257	0.000458	CcSEcCtD
Oxcarbazepine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000257	0.000458	CcSEcCtD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000257	0.00494	CbGpPWpGaD
Oxcarbazepine—Flushing—Doxorubicin—urinary bladder cancer	0.000256	0.000456	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000256	0.000456	CcSEcCtD
Oxcarbazepine—Flatulence—Epirubicin—urinary bladder cancer	0.000256	0.000455	CcSEcCtD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000255	0.0049	CbGpPWpGaD
Oxcarbazepine—Tension—Epirubicin—urinary bladder cancer	0.000255	0.000453	CcSEcCtD
Oxcarbazepine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000254	0.000453	CcSEcCtD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000254	0.00488	CbGpPWpGaD
Oxcarbazepine—Nervousness—Epirubicin—urinary bladder cancer	0.000252	0.000449	CcSEcCtD
Oxcarbazepine—Back pain—Epirubicin—urinary bladder cancer	0.000251	0.000447	CcSEcCtD
Oxcarbazepine—Angiopathy—Doxorubicin—urinary bladder cancer	0.00025	0.000446	CcSEcCtD
Oxcarbazepine—Malaise—Methotrexate—urinary bladder cancer	0.00025	0.000445	CcSEcCtD
Oxcarbazepine—Dizziness—Etoposide—urinary bladder cancer	0.00025	0.000445	CcSEcCtD
Oxcarbazepine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000249	0.000444	CcSEcCtD
Oxcarbazepine—Vertigo—Methotrexate—urinary bladder cancer	0.000249	0.000444	CcSEcCtD
Oxcarbazepine—Leukopenia—Methotrexate—urinary bladder cancer	0.000248	0.000442	CcSEcCtD
Oxcarbazepine—Chills—Doxorubicin—urinary bladder cancer	0.000248	0.000441	CcSEcCtD
Oxcarbazepine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000247	0.000439	CcSEcCtD
Oxcarbazepine—Nausea—Cisplatin—urinary bladder cancer	0.000245	0.000436	CcSEcCtD
Oxcarbazepine—Vision blurred—Epirubicin—urinary bladder cancer	0.000245	0.000436	CcSEcCtD
Oxcarbazepine—Alopecia—Doxorubicin—urinary bladder cancer	0.000244	0.000434	CcSEcCtD
Oxcarbazepine—Cough—Methotrexate—urinary bladder cancer	0.000242	0.000431	CcSEcCtD
Oxcarbazepine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000242	0.00043	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000241	0.000429	CcSEcCtD
Oxcarbazepine—Convulsion—Methotrexate—urinary bladder cancer	0.00024	0.000428	CcSEcCtD
Oxcarbazepine—Vomiting—Etoposide—urinary bladder cancer	0.00024	0.000428	CcSEcCtD
Oxcarbazepine—Malnutrition—Doxorubicin—urinary bladder cancer	0.00024	0.000428	CcSEcCtD
Oxcarbazepine—Agitation—Epirubicin—urinary bladder cancer	0.000239	0.000425	CcSEcCtD
Oxcarbazepine—Rash—Etoposide—urinary bladder cancer	0.000238	0.000424	CcSEcCtD
Oxcarbazepine—Dermatitis—Etoposide—urinary bladder cancer	0.000238	0.000424	CcSEcCtD
Oxcarbazepine—ALB—Folate Metabolism—SOD2—urinary bladder cancer	0.000238	0.00456	CbGpPWpGaD
Oxcarbazepine—Headache—Etoposide—urinary bladder cancer	0.000237	0.000422	CcSEcCtD
Oxcarbazepine—Flatulence—Doxorubicin—urinary bladder cancer	0.000237	0.000421	CcSEcCtD
Oxcarbazepine—Myalgia—Methotrexate—urinary bladder cancer	0.000236	0.00042	CcSEcCtD
Oxcarbazepine—Arthralgia—Methotrexate—urinary bladder cancer	0.000236	0.00042	CcSEcCtD
Oxcarbazepine—Chest pain—Methotrexate—urinary bladder cancer	0.000236	0.00042	CcSEcCtD
Oxcarbazepine—Tension—Doxorubicin—urinary bladder cancer	0.000236	0.00042	CcSEcCtD
Oxcarbazepine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000235	0.000419	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000235	0.000418	CcSEcCtD
Oxcarbazepine—Malaise—Epirubicin—urinary bladder cancer	0.000234	0.000417	CcSEcCtD
Oxcarbazepine—Discomfort—Methotrexate—urinary bladder cancer	0.000233	0.000415	CcSEcCtD
Oxcarbazepine—Nervousness—Doxorubicin—urinary bladder cancer	0.000233	0.000415	CcSEcCtD
Oxcarbazepine—Vertigo—Epirubicin—urinary bladder cancer	0.000233	0.000415	CcSEcCtD
Oxcarbazepine—Syncope—Epirubicin—urinary bladder cancer	0.000233	0.000414	CcSEcCtD
Oxcarbazepine—Leukopenia—Epirubicin—urinary bladder cancer	0.000232	0.000414	CcSEcCtD
Oxcarbazepine—Back pain—Doxorubicin—urinary bladder cancer	0.000232	0.000414	CcSEcCtD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000232	0.00445	CbGpPWpGaD
Oxcarbazepine—Palpitations—Epirubicin—urinary bladder cancer	0.000229	0.000408	CcSEcCtD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000228	0.00439	CbGpPWpGaD
Oxcarbazepine—Confusional state—Methotrexate—urinary bladder cancer	0.000228	0.000406	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000228	0.000406	CcSEcCtD
Oxcarbazepine—ALB—Folate Metabolism—GPX1—urinary bladder cancer	0.000227	0.00435	CbGpPWpGaD
Oxcarbazepine—Cough—Epirubicin—urinary bladder cancer	0.000227	0.000403	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000226	0.000403	CcSEcCtD
Oxcarbazepine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000226	0.000403	CcSEcCtD
Oxcarbazepine—Convulsion—Epirubicin—urinary bladder cancer	0.000225	0.0004	CcSEcCtD
Oxcarbazepine—Infection—Methotrexate—urinary bladder cancer	0.000225	0.0004	CcSEcCtD
Oxcarbazepine—Nausea—Etoposide—urinary bladder cancer	0.000225	0.0004	CcSEcCtD
Oxcarbazepine—Hypertension—Epirubicin—urinary bladder cancer	0.000224	0.000399	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000223	0.000397	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000222	0.000395	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000222	0.000395	CcSEcCtD
Oxcarbazepine—Myalgia—Epirubicin—urinary bladder cancer	0.000221	0.000393	CcSEcCtD
Oxcarbazepine—Chest pain—Epirubicin—urinary bladder cancer	0.000221	0.000393	CcSEcCtD
Oxcarbazepine—Arthralgia—Epirubicin—urinary bladder cancer	0.000221	0.000393	CcSEcCtD
Oxcarbazepine—Agitation—Doxorubicin—urinary bladder cancer	0.000221	0.000393	CcSEcCtD
Oxcarbazepine—Anxiety—Epirubicin—urinary bladder cancer	0.00022	0.000392	CcSEcCtD
Oxcarbazepine—Skin disorder—Methotrexate—urinary bladder cancer	0.00022	0.000391	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00022	0.000391	CcSEcCtD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00022	0.00422	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00022	0.00422	CbGpPWpGaD
Oxcarbazepine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000219	0.00039	CcSEcCtD
Oxcarbazepine—Discomfort—Epirubicin—urinary bladder cancer	0.000218	0.000389	CcSEcCtD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000217	0.00417	CbGpPWpGaD
Oxcarbazepine—Malaise—Doxorubicin—urinary bladder cancer	0.000217	0.000386	CcSEcCtD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000216	0.00416	CbGpPWpGaD
Oxcarbazepine—Dry mouth—Epirubicin—urinary bladder cancer	0.000216	0.000385	CcSEcCtD
Oxcarbazepine—Vertigo—Doxorubicin—urinary bladder cancer	0.000216	0.000384	CcSEcCtD
Oxcarbazepine—Anorexia—Methotrexate—urinary bladder cancer	0.000216	0.000384	CcSEcCtD
Oxcarbazepine—Syncope—Doxorubicin—urinary bladder cancer	0.000215	0.000383	CcSEcCtD
Oxcarbazepine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000215	0.000383	CcSEcCtD
Oxcarbazepine—Confusional state—Epirubicin—urinary bladder cancer	0.000214	0.00038	CcSEcCtD
Oxcarbazepine—Palpitations—Doxorubicin—urinary bladder cancer	0.000212	0.000378	CcSEcCtD
Oxcarbazepine—SCN5A—L1CAM interactions—SRC—urinary bladder cancer	0.000212	0.00407	CbGpPWpGaD
Oxcarbazepine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000212	0.000377	CcSEcCtD
Oxcarbazepine—Hypotension—Methotrexate—urinary bladder cancer	0.000212	0.000377	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000211	0.000376	CcSEcCtD
Oxcarbazepine—Infection—Epirubicin—urinary bladder cancer	0.000211	0.000375	CcSEcCtD
Oxcarbazepine—Cough—Doxorubicin—urinary bladder cancer	0.00021	0.000373	CcSEcCtD
Oxcarbazepine—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	0.000209	0.00402	CbGpPWpGaD
Oxcarbazepine—Shock—Epirubicin—urinary bladder cancer	0.000208	0.000371	CcSEcCtD
Oxcarbazepine—Convulsion—Doxorubicin—urinary bladder cancer	0.000208	0.00037	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000208	0.00037	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000207	0.000369	CcSEcCtD
Oxcarbazepine—Hypertension—Doxorubicin—urinary bladder cancer	0.000207	0.000369	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—HPGDS—urinary bladder cancer	0.000207	0.00397	CbGpPWpGaD
Oxcarbazepine—Tachycardia—Epirubicin—urinary bladder cancer	0.000207	0.000368	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000206	0.000367	CcSEcCtD
Oxcarbazepine—Skin disorder—Epirubicin—urinary bladder cancer	0.000206	0.000366	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000205	0.000365	CcSEcCtD
Oxcarbazepine—Insomnia—Methotrexate—urinary bladder cancer	0.000205	0.000365	CcSEcCtD
Oxcarbazepine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000205	0.000364	CcSEcCtD
Oxcarbazepine—Chest pain—Doxorubicin—urinary bladder cancer	0.000205	0.000364	CcSEcCtD
Oxcarbazepine—Myalgia—Doxorubicin—urinary bladder cancer	0.000205	0.000364	CcSEcCtD
Oxcarbazepine—Anxiety—Doxorubicin—urinary bladder cancer	0.000204	0.000363	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000203	0.000362	CcSEcCtD
Oxcarbazepine—Discomfort—Doxorubicin—urinary bladder cancer	0.000202	0.00036	CcSEcCtD
Oxcarbazepine—Anorexia—Epirubicin—urinary bladder cancer	0.000202	0.00036	CcSEcCtD
Oxcarbazepine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000202	0.000359	CcSEcCtD
Oxcarbazepine—Somnolence—Methotrexate—urinary bladder cancer	0.000201	0.000358	CcSEcCtD
Oxcarbazepine—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000201	0.00386	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTT1—urinary bladder cancer	0.000201	0.00385	CbGpPWpGaD
Oxcarbazepine—Dry mouth—Doxorubicin—urinary bladder cancer	0.0002	0.000356	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.0002	0.00384	CbGpPWpGaD
Oxcarbazepine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000199	0.000355	CcSEcCtD
Oxcarbazepine—Hypotension—Epirubicin—urinary bladder cancer	0.000198	0.000352	CcSEcCtD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000198	0.0038	CbGpPWpGaD
Oxcarbazepine—Confusional state—Doxorubicin—urinary bladder cancer	0.000198	0.000352	CcSEcCtD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000197	0.00379	CbGpPWpGaD
Oxcarbazepine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000197	0.00035	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000196	0.000349	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000195	0.000348	CcSEcCtD
Oxcarbazepine—Fatigue—Methotrexate—urinary bladder cancer	0.000195	0.000347	CcSEcCtD
Oxcarbazepine—Infection—Doxorubicin—urinary bladder cancer	0.000195	0.000347	CcSEcCtD
Oxcarbazepine—Pain—Methotrexate—urinary bladder cancer	0.000194	0.000345	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000193	0.000344	CcSEcCtD
Oxcarbazepine—Shock—Doxorubicin—urinary bladder cancer	0.000193	0.000343	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000192	0.000342	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000192	0.000342	CcSEcCtD
Oxcarbazepine—Insomnia—Epirubicin—urinary bladder cancer	0.000192	0.000341	CcSEcCtD
Oxcarbazepine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000191	0.000341	CcSEcCtD
Oxcarbazepine—Skin disorder—Doxorubicin—urinary bladder cancer	0.00019	0.000339	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00019	0.000337	CcSEcCtD
Oxcarbazepine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000189	0.000336	CcSEcCtD
Oxcarbazepine—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000189	0.00363	CbGpPWpGaD
Oxcarbazepine—Somnolence—Epirubicin—urinary bladder cancer	0.000188	0.000335	CcSEcCtD
Oxcarbazepine—Anorexia—Doxorubicin—urinary bladder cancer	0.000187	0.000333	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000187	0.000332	CcSEcCtD
Oxcarbazepine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000187	0.000332	CcSEcCtD
Oxcarbazepine—SCN5A—L1CAM interactions—EGFR—urinary bladder cancer	0.000186	0.00357	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000185	0.00033	CcSEcCtD
Oxcarbazepine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000184	0.000328	CcSEcCtD
Oxcarbazepine—Hypotension—Doxorubicin—urinary bladder cancer	0.000183	0.000326	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000183	0.000326	CcSEcCtD
Oxcarbazepine—Fatigue—Epirubicin—urinary bladder cancer	0.000183	0.000325	CcSEcCtD
Oxcarbazepine—Constipation—Epirubicin—urinary bladder cancer	0.000181	0.000323	CcSEcCtD
Oxcarbazepine—Pain—Epirubicin—urinary bladder cancer	0.000181	0.000323	CcSEcCtD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000181	0.00347	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.00018	0.00346	CbGpPWpGaD
Oxcarbazepine—Urticaria—Methotrexate—urinary bladder cancer	0.00018	0.00032	CcSEcCtD
Oxcarbazepine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000179	0.000319	CcSEcCtD
Oxcarbazepine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000179	0.000319	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000179	0.000318	CcSEcCtD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000178	0.00342	CbGpPWpGaD
Oxcarbazepine—Insomnia—Doxorubicin—urinary bladder cancer	0.000177	0.000316	CcSEcCtD
Oxcarbazepine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000175	0.000311	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000175	0.000311	CcSEcCtD
Oxcarbazepine—Somnolence—Doxorubicin—urinary bladder cancer	0.000174	0.00031	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000173	0.000308	CcSEcCtD
Oxcarbazepine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000173	0.000307	CcSEcCtD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000172	0.00331	CbGpPWpGaD
Oxcarbazepine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00017	0.000303	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000169	0.000301	CcSEcCtD
Oxcarbazepine—Fatigue—Doxorubicin—urinary bladder cancer	0.000169	0.000301	CcSEcCtD
Oxcarbazepine—Urticaria—Epirubicin—urinary bladder cancer	0.000168	0.0003	CcSEcCtD
Oxcarbazepine—Pain—Doxorubicin—urinary bladder cancer	0.000168	0.000298	CcSEcCtD
Oxcarbazepine—Constipation—Doxorubicin—urinary bladder cancer	0.000168	0.000298	CcSEcCtD
Oxcarbazepine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000168	0.000298	CcSEcCtD
Oxcarbazepine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000168	0.000298	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000167	0.000297	CcSEcCtD
Oxcarbazepine—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000166	0.00319	CbGpPWpGaD
Oxcarbazepine—Asthenia—Methotrexate—urinary bladder cancer	0.000162	0.000289	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000162	0.000288	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00016	0.000285	CcSEcCtD
Oxcarbazepine—Pruritus—Methotrexate—urinary bladder cancer	0.00016	0.000285	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.00016	0.00307	CbGpPWpGaD
Oxcarbazepine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000156	0.000278	CcSEcCtD
Oxcarbazepine—Urticaria—Doxorubicin—urinary bladder cancer	0.000156	0.000277	CcSEcCtD
Oxcarbazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000156	0.00299	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000155	0.00298	CbGpPWpGaD
Oxcarbazepine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000155	0.000276	CcSEcCtD
Oxcarbazepine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000155	0.000276	CcSEcCtD
Oxcarbazepine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000155	0.000276	CcSEcCtD
Oxcarbazepine—Asthenia—Epirubicin—urinary bladder cancer	0.000152	0.000271	CcSEcCtD
Oxcarbazepine—Pruritus—Epirubicin—urinary bladder cancer	0.00015	0.000267	CcSEcCtD
Oxcarbazepine—Dizziness—Methotrexate—urinary bladder cancer	0.00015	0.000267	CcSEcCtD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00015	0.00287	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000148	0.00285	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000148	0.00284	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000145	0.000258	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000144	0.000257	CcSEcCtD
Oxcarbazepine—Vomiting—Methotrexate—urinary bladder cancer	0.000144	0.000256	CcSEcCtD
Oxcarbazepine—Rash—Methotrexate—urinary bladder cancer	0.000143	0.000254	CcSEcCtD
Oxcarbazepine—Dermatitis—Methotrexate—urinary bladder cancer	0.000143	0.000254	CcSEcCtD
Oxcarbazepine—Headache—Methotrexate—urinary bladder cancer	0.000142	0.000252	CcSEcCtD
Oxcarbazepine—Asthenia—Doxorubicin—urinary bladder cancer	0.000141	0.00025	CcSEcCtD
Oxcarbazepine—Dizziness—Epirubicin—urinary bladder cancer	0.00014	0.000249	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000139	0.00267	CbGpPWpGaD
Oxcarbazepine—Pruritus—Doxorubicin—urinary bladder cancer	0.000139	0.000247	CcSEcCtD
Oxcarbazepine—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.000138	0.00265	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000137	0.00263	CbGpPWpGaD
Oxcarbazepine—Vomiting—Epirubicin—urinary bladder cancer	0.000135	0.00024	CcSEcCtD
Oxcarbazepine—Nausea—Methotrexate—urinary bladder cancer	0.000134	0.000239	CcSEcCtD
Oxcarbazepine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000134	0.000239	CcSEcCtD
Oxcarbazepine—Rash—Epirubicin—urinary bladder cancer	0.000134	0.000238	CcSEcCtD
Oxcarbazepine—Dermatitis—Epirubicin—urinary bladder cancer	0.000133	0.000238	CcSEcCtD
Oxcarbazepine—Headache—Epirubicin—urinary bladder cancer	0.000133	0.000236	CcSEcCtD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000131	0.00253	CbGpPWpGaD
Oxcarbazepine—Dizziness—Doxorubicin—urinary bladder cancer	0.00013	0.000231	CcSEcCtD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000129	0.00247	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000128	0.00245	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000126	0.00242	CbGpPWpGaD
Oxcarbazepine—Nausea—Epirubicin—urinary bladder cancer	0.000126	0.000224	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—NCOR1—urinary bladder cancer	0.000125	0.00241	CbGpPWpGaD
Oxcarbazepine—Vomiting—Doxorubicin—urinary bladder cancer	0.000125	0.000222	CcSEcCtD
Oxcarbazepine—ALB—Folate Metabolism—IL2—urinary bladder cancer	0.000124	0.00238	CbGpPWpGaD
Oxcarbazepine—Rash—Doxorubicin—urinary bladder cancer	0.000124	0.00022	CcSEcCtD
Oxcarbazepine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000124	0.00022	CcSEcCtD
Oxcarbazepine—Headache—Doxorubicin—urinary bladder cancer	0.000123	0.000219	CcSEcCtD
Oxcarbazepine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.00012	0.00231	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.00012	0.00231	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000119	0.00228	CbGpPWpGaD
Oxcarbazepine—Nausea—Doxorubicin—urinary bladder cancer	0.000116	0.000207	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000115	0.00222	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.000111	0.00213	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—RHOA—urinary bladder cancer	0.000109	0.0021	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000107	0.00206	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000107	0.00206	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000106	0.00204	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000106	0.00204	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—ERBB2—urinary bladder cancer	0.000101	0.00195	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—CDK4—urinary bladder cancer	9.9e-05	0.0019	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	9.88e-05	0.0019	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.74e-05	0.00187	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.61e-05	0.00185	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	9.33e-05	0.00179	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TNF—urinary bladder cancer	9.01e-05	0.00173	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—PPARG—urinary bladder cancer	8.99e-05	0.00173	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.75e-05	0.00168	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MMP9—urinary bladder cancer	8.69e-05	0.00167	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—CREBBP—urinary bladder cancer	8.64e-05	0.00166	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	8.52e-05	0.00164	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	8.07e-05	0.00155	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	8.07e-05	0.00155	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—SRC—urinary bladder cancer	8.02e-05	0.00154	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TP53—urinary bladder cancer	7.94e-05	0.00153	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	7.81e-05	0.0015	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	7.39e-05	0.00142	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTZ1—urinary bladder cancer	7.34e-05	0.00141	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	7.23e-05	0.00139	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.16e-05	0.00137	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—EGFR—urinary bladder cancer	7.03e-05	0.00135	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTO2—urinary bladder cancer	6.95e-05	0.00134	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NAT1—urinary bladder cancer	6.95e-05	0.00134	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.84e-05	0.00131	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	6.65e-05	0.00128	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—KRAS—urinary bladder cancer	6.64e-05	0.00127	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	6.59e-05	0.00126	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.46e-05	0.00124	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.38e-05	0.00122	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—UGT2B7—urinary bladder cancer	6.36e-05	0.00122	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	6.28e-05	0.00121	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	6.24e-05	0.0012	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	6.24e-05	0.0012	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	6.2e-05	0.00119	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.14e-05	0.00118	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	6.12e-05	0.00118	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	6.12e-05	0.00118	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.94e-05	0.00114	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.91e-05	0.00114	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—EP300—urinary bladder cancer	5.88e-05	0.00113	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.86e-05	0.00113	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP4B1—urinary bladder cancer	5.73e-05	0.0011	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—SRC—urinary bladder cancer	5.72e-05	0.0011	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.71e-05	0.0011	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—HRAS—urinary bladder cancer	5.64e-05	0.00108	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	5.61e-05	0.00108	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IFNA2—urinary bladder cancer	5.46e-05	0.00105	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC19A1—urinary bladder cancer	5.41e-05	0.00104	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PRSS3—urinary bladder cancer	5.27e-05	0.00101	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	5.14e-05	0.000987	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	5.01e-05	0.000963	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	4.89e-05	0.00094	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.85e-05	0.000932	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TNF—urinary bladder cancer	4.77e-05	0.000917	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	4.74e-05	0.00091	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.73e-05	0.000909	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	4.71e-05	0.000904	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	4.42e-05	0.00085	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.23e-05	0.000812	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TYMP—urinary bladder cancer	4.21e-05	0.000809	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	4.11e-05	0.000788	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.05e-05	0.000777	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	4.03e-05	0.000773	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.96e-05	0.000761	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PLAU—urinary bladder cancer	3.87e-05	0.000744	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.82e-05	0.000733	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NAT2—urinary bladder cancer	3.81e-05	0.000732	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.79e-05	0.000729	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.78e-05	0.000726	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.75e-05	0.000721	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.75e-05	0.000721	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.63e-05	0.000698	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	3.54e-05	0.000679	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	3.54e-05	0.000679	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.43e-05	0.000659	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	3.43e-05	0.000659	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.42e-05	0.000657	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—RRM2—urinary bladder cancer	3.29e-05	0.000632	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CREBBP—urinary bladder cancer	3.2e-05	0.000614	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF1—urinary bladder cancer	3.16e-05	0.000606	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.09e-05	0.000594	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HPGDS—urinary bladder cancer	3.05e-05	0.000585	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ENO2—urinary bladder cancer	3.05e-05	0.000585	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.03e-05	0.000582	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTT1—urinary bladder cancer	2.95e-05	0.000567	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.95e-05	0.000567	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.92e-05	0.000561	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.91e-05	0.000559	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—RHOA—urinary bladder cancer	2.89e-05	0.000555	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.85e-05	0.000548	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.84e-05	0.000546	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.77e-05	0.000531	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.73e-05	0.000525	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.73e-05	0.000525	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.72e-05	0.000522	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.65e-05	0.000509	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.61e-05	0.000502	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NQO1—urinary bladder cancer	2.46e-05	0.000472	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IL2—urinary bladder cancer	2.43e-05	0.000466	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.38e-05	0.000458	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.38e-05	0.000457	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.27e-05	0.000437	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.21e-05	0.000425	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.2e-05	0.000423	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.19e-05	0.00042	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.19e-05	0.00042	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—EP300—urinary bladder cancer	2.18e-05	0.000418	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.14e-05	0.000411	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SRC—urinary bladder cancer	2.12e-05	0.000406	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2.09e-05	0.000402	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.08e-05	0.000399	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.06e-05	0.000395	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.05e-05	0.000395	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTP1—urinary bladder cancer	2.05e-05	0.000393	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.98e-05	0.000381	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.93e-05	0.000371	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TYMS—urinary bladder cancer	1.9e-05	0.000366	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOR1—urinary bladder cancer	1.88e-05	0.000361	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTM1—urinary bladder cancer	1.88e-05	0.000361	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.86e-05	0.000358	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.84e-05	0.000353	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GPX1—urinary bladder cancer	1.8e-05	0.000346	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.78e-05	0.000342	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.78e-05	0.000341	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ERCC2—urinary bladder cancer	1.77e-05	0.00034	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KRAS—urinary bladder cancer	1.75e-05	0.000337	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.71e-05	0.000328	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.69e-05	0.000324	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.69e-05	0.000324	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTHFR—urinary bladder cancer	1.66e-05	0.000319	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.64e-05	0.000316	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.64e-05	0.000316	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.62e-05	0.000311	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.59e-05	0.000306	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.59e-05	0.000305	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.57e-05	0.000301	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TP53—urinary bladder cancer	1.56e-05	0.000299	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.5e-05	0.000289	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.49e-05	0.000287	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—HRAS—urinary bladder cancer	1.49e-05	0.000286	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPARG—urinary bladder cancer	1.35e-05	0.000259	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.33e-05	0.000255	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CREBBP—urinary bladder cancer	1.3e-05	0.000249	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.23e-05	0.000237	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.21e-05	0.000233	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.16e-05	0.000223	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.11e-05	0.000212	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.07e-05	0.000206	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS2—urinary bladder cancer	1.06e-05	0.000204	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.03e-05	0.000197	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.02e-05	0.000197	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.02e-05	0.000195	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.02e-05	0.000195	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.73e-06	0.000187	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.55e-06	0.000183	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	9.52e-06	0.000183	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTEN—urinary bladder cancer	9.25e-06	0.000178	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.98e-06	0.000172	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—EP300—urinary bladder cancer	8.82e-06	0.000169	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	8.31e-06	0.00016	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.92e-06	0.000152	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.28e-06	0.00014	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.99e-06	0.000134	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.73e-06	0.00011	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.99e-06	9.59e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.76e-06	9.15e-05	CbGpPWpGaD
